BioCentury
ARTICLE | Company News

MediVas LCC, Duravest deal

July 25, 2005 7:00 AM UTC

DUVT's Estracure subsidiary (Montreal, Quebec) received exclusive rights to use MediVas' MediVas polyesteramide (PEA) copolymer drug delivery technology to develop a 17-beta Estradiol drug-eluting ste...